Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GTx (Fareston)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

US commercial rights of Fareston. It consist of rights to market, distribute and sell Fareston in the United States. Fareston is a pharmaceutical drug for the treatment of metastatic breast cancer in postmenopausal women.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 175 Toyota Plaza
  • 7th Floor
  • Memphis, TN 38103
  • United States

GTx (Fareston) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GTx (Fareston)‘s full profile, request access.

Request full access to PitchBook

GTx (Fareston) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore GTx (Fareston)‘s full profile, request access.

Request full access to PitchBook